• OPEN AN ACCOUNT
Indian Indices
Sensex
77,235.46 -492.70
( -0.63%)
Global Indices
Nasdaq
53,489.46 -263.95
(-0.49%)
Dow Jones
7,767.06 -39.70
(-0.51%)
Hang Seng
67,388.40 -1,831.85
(-2.65%)
Nikkei 225
10,727.81 -22.30
(-0.21%)
Forex
USD-INR
95.53 0.14
(0.14%)
EUR-INR
110.53 0.55
(0.50%)
GBP-INR
129.27 0.59
(0.46%)
JPY-INR
0.60 0.00
(0.19%)

EQUITY - MARKET SCREENER

Fredun Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
539730
INE194R01017
163.1433353
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
FREDUN
54.09
2403.56
EPS(TTM)
Face Value()
Div & Yield %
26.87
10
0.02
 

Asahi India Glass ends higher after Q1 PAT jumps over 172% YoY to Rs 149 crore
Aug 05,2026

Revenue from operations rose by 14.2% year-on-year (YoY) to Rs 1,392.07 crore during the period under review.

Total expenses increased by 4.5% to Rs 1,216.26 crore in Q1 FY27 from Rs 1,163.68 crore in Q1 FY26. The fall in raw material costs (down 21.4% YoY) was more than offset by higher power & fuel charges (up 29.8% YoY), higher employee expenses (up 13.7% YoY) and higher other expenses (up 28.2% YoY).

Profit before tax in Q1 FY27 stood at Rs 202.65 crore, up 167.5% from Rs 75.77 crore in Q1 FY26.

Asahi India Glass operates under two strategic business units (SBUs), namely, auto glass (laminated and tempered glass) and float glass (architectural glass and consumer glass) The company has 13 plants and 10 sub-assembly units-cum-warehouses for manufacturing various types of glasses across India.